BACKGROUND: Higher levels of baseline pulse wave velocity (PWV) have been associated with longitudinal decline in renal function in patients with kidney disease. We examined longitudinal decline in renal function in relation to levels of PWV. We hypothesized that longitudinal decline in renal function in a community-based, nonclinic sample would be associated with higher levels of PWV. METHODS: We conducted a 4-5 year longitudinal study with 482 community-living individuals free from acute stroke, dementia, and end-stage renal disease (mean age = 60.9 years; 59% women; 93.2% white; 10% with diabetes mellitus; mean estimated glomerular filtration rate (eGFR) = 79.2 ml/min/1.73 m2). Multiple linear regression analyses were used to examine the association between changes in renal function (eGFR and serum creatinine) from baseline to follow-up and PWV levels at follow-up, the outcome measure. Regression coefficients were adjusted for age, sex, education, race/ethnicity, weight, activity level, mean arterial pressure, treatment of hypertension, and cardiovascular risk factors. RESULTS: With adjustment for covariables, decline in renal function was associated with higher levels of PWV over a mean follow-up of 4.68 years. CONCLUSIONS: Decline in renal functioning from baseline levels measured 4-5 years before measurement of PWV is related to higher levels of PWV in a community sample.
BACKGROUND: Higher levels of baseline pulse wave velocity (PWV) have been associated with longitudinal decline in renal function in patients with kidney disease. We examined longitudinal decline in renal function in relation to levels of PWV. We hypothesized that longitudinal decline in renal function in a community-based, nonclinic sample would be associated with higher levels of PWV. METHODS: We conducted a 4-5 year longitudinal study with 482 community-living individuals free from acute stroke, dementia, and end-stage renal disease (mean age = 60.9 years; 59% women; 93.2% white; 10% with diabetes mellitus; mean estimated glomerular filtration rate (eGFR) = 79.2 ml/min/1.73 m2). Multiple linear regression analyses were used to examine the association between changes in renal function (eGFR and serum creatinine) from baseline to follow-up and PWV levels at follow-up, the outcome measure. Regression coefficients were adjusted for age, sex, education, race/ethnicity, weight, activity level, mean arterial pressure, treatment of hypertension, and cardiovascular risk factors. RESULTS: With adjustment for covariables, decline in renal function was associated with higher levels of PWV over a mean follow-up of 4.68 years. CONCLUSIONS: Decline in renal functioning from baseline levels measured 4-5 years before measurement of PWV is related to higher levels of PWV in a community sample.
Authors: Rachel P Wildman; Ghada N Farhat; Ami S Patel; Rachel H Mackey; Sarah Brockwell; Trina Thompson; Kim Sutton-Tyrrell Journal: Hypertension Date: 2004-12-13 Impact factor: 10.190
Authors: Sandrine C Millasseau; Andrew D Stewart; Sundip J Patel; Simon R Redwood; Philip J Chowienczyk Journal: Hypertension Date: 2005-01-10 Impact factor: 10.190
Authors: Magdalena Madero; Carmen Peralta; Ronit Katz; Robert Canada; Linda Fried; Samer Najjar; Michael Shlipak; Eleanor Simonsick; Edward Lakatta; Kushang Patel; Dena Rifkin; Marquis Hawkins; Anne Newman; Mark Sarnak Journal: Clin J Am Soc Nephrol Date: 2012-12-27 Impact factor: 8.237
Authors: Stephen L Seliger; David S Siscovick; Catherine O Stehman-Breen; Daniel L Gillen; Annette Fitzpatrick; Anthony Bleyer; Lew H Kuller Journal: J Am Soc Nephrol Date: 2004-07 Impact factor: 10.121
Authors: A M Wolf; D J Hunter; G A Colditz; J E Manson; M J Stampfer; K A Corsano; B Rosner; A Kriska; W C Willett Journal: Int J Epidemiol Date: 1994-10 Impact factor: 7.196
Authors: Elizabeth G Holliday; Matthew Traylor; Rainer Malik; Stephen Bevan; Jane Maguire; Simon A Koblar; Jonathan Sturm; Graeme J Hankey; Christopher Oldmeadow; Mark McEvoy; Cathie Sudlow; Peter M Rothwell; Josef Coresh; Pavel Hamet; Johanne Tremblay; Stephen T Turner; Mariza de Andrade; Madhumathi Rao; Reinhold Schmidt; Peter A Crick; Antonietta Robino; Carmen A Peralta; J Wouter Jukema; Paul Mitchell; Sylvia E Rosas; Jie Jin Wang; Rodney J Scott; Martin Dichgans; Braxton D Mitchell; W H Linda Kao; Caroline S Fox; Christopher Levi; John Attia; Hugh S Markus Journal: Stroke Date: 2014-10-28 Impact factor: 7.914
Authors: Michael E Seifert; Lisa de Las Fuentes; Charles Ginsberg; Marcos Rothstein; Dennis J Dietzen; Steven C Cheng; Will Ross; David Windus; Victor G Dávila-Román; Keith A Hruska Journal: Am J Nephrol Date: 2014-05-06 Impact factor: 3.754
Authors: Catherine Fortier; Fabrice Mac-Way; Sacha A De Serres; Karine Marquis; Pierre Douville; Simon Desmeules; Richard Larivière; Mohsen Agharazii Journal: Am J Hypertens Date: 2014-04-02 Impact factor: 2.689
Authors: Merrill F Elias; Kevin Sullivan; Gregory A Dore; Michael A Robbins Journal: J Clin Hypertens (Greenwich) Date: 2013-11-04 Impact factor: 3.738